Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
Nuclear Medicine Communications|July 1, 1993
Evaluation of 99Tcm-teboroxime scintigraphy for the differentiation of reversible from fixed defects: comparison with 201T1 redistribution and reinjection imagingG Bisi, R Sciagrà, G M Santoro, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 1, 1995
Technetium-99m-sestamibi imaging with nitrate infusion to detect viable hibernating myocardium and predict postrevascularization recoveryG Bisi, R Sciagrà, G M Santoro, et al.
American Journal of Cardiac Imaging|July 1, 1995
Nitrate versus rest myocardial scintigraphy with technetium 99m-sestamibi: relationship of tracer uptake to regional left ventricular function and its significance in the detection of viable hibernating myocardiumR Sciagrà, G Bisi, G M Santoro, et al.
Giornale Italiano Di Cardiologia|February 1, 1993
[Myocardial scintigraphy with Tc-99m-MIBI for assessing the extent and severity of coronary disease: a comparison with thallium-201 and equilibrium angiocardioscintigraphy]M Leoncini, R Sciagrà, G Bisi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1994
Sublingual isosorbide dinitrate to improve technetium-99m-teboroxime perfusion defect reversibilityG Bisi, R Sciagrà, G M Santoro, et al.
Giornale Italiano Di Cardiologia|January 1, 1981
[Hemodynamic correlation of the systolic movement of the aortic root]F Fantini, G A Barletta, M Di Donato, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|September 1, 1986
[Comparison of long-term pH-metry and radiological studies in the diagnosis of gastroesophageal reflux]F Balli, S Forese, G C Bernini, et al.
Nuclear Medicine Communications|September 28, 2002
Prognosis of hibernating myocardium is independent of recovery of function: evidence from a routine based follow-up studyV Podio, M T Spinnler, G Bertuccio, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1994
Evaluation of coronary artery disease using technetium-99m-sestamibi first-pass and perfusion imaging with dipyridamole infusionR Sciagrà, G Bisi, G M Santoro, et al.
Nuclear Medicine Communications|November 1, 1993
Evaluation of coronary artery disease extent using 99Tcm-sestamibi: comparison of dipyridamole versus exercise and of planar versus tomographic imagingG Bisi, R Sciagra, G M Santoro, et al.
Pageof 10